Prognostic Importance of Quantitative Magnetic Resonance Imaging for Evaluation of Pancreatic Steatosis in Patients with Pancreatic Cancer
1. Finding patients with pancreatic cancer (in all stages), before any treatment. 2. Non invasively quantify fatty infiltration of pancreas using, MRI DIXON Scan in pancreatic cancer patient relatively to liver. 3. Measuring cell-free blood DNA in those patients for evaluating the aggressiveness of the disease. 4. Quantify the prognostic significance of pancreatic steatosis in comparison with clinical and pathological prognostic indexes used today.
Study Type
OBSERVATIONAL
Enrollment
30
Soroka university medical center
Beersheba, Israel
RECRUITINGPercentage of fat in pancreas measured in the head, body and tail excluding the lesion area.
measuring Pancreatic Steatosis in patients with pancreatic cancer using MRI DIXON scan, at 24 hours before chemotherapy starting.
Time frame: at 24 hours before chemotherapy starting
Blood levels of free DNA
Correlation of free DNA level and metastatic spread.
Time frame: The blood sample taken 15 minutes prior to MRI study, at time of IV access.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.